Advertising
Showing 1 to 15 of 28 entries
HOLD
Broke through the 200-day moving average at about $1.50. Looks like the momentum may start to peter out but there is some pretty good support around $1.40. If her broke that, you should Sell.
biotechnology / pharmaceutical
DON'T BUY
Has disappointed everyone for a long time. Didn't get approval on their product. Stock has been decimated. Thinks the worst is over, but it will be a long recovery. He was actually Short the stock for a while. If you own, Hold and see what they do, but don't be a buyer.
biotechnology / pharmaceutical
SELL
Has been a major disappointment. Guided that approvals would be fairly easy to receive, which didn't happen. Trials have been okay, not all that inclusive, so there is a lot of uncertainty.
biotechnology / pharmaceutical
BUY
Has been doing fairly well recently because they had their European and Canadian approval for their painkiller. Once they get the US of the way, it should be back over the $7 mark.
biotechnology / pharmaceutical
BUY
It is a small stock. Believes it will be a winner.
biotechnology / pharmaceutical
WATCH
Entering into a licensing/distribution agreement with Purdue Pharma in the US. Did a disatrous financing last year and the stock sold off. This deal was a rabbit pulled out of a hat. The stock will probably flatline for a bit after this deal. Best to see quarter after quarter how revenues kick in.
biotechnology / pharmaceutical
DON'T BUY
Received approval in France for its drug tramadol. Has stubbed its toes many times with investors. Large outstanding stock holding (40 Million?) could come out and flood the market.
biotechnology / pharmaceutical
DON'T BUY
Drug companies in general scare value investors. Drugs they produce might injure or kill people. Also there's a history of companies suing each other because of infringement on property rights which can tie up a small company like this. Although they got French approval, FDA could be a whole different matter.
biotechnology / pharmaceutical
WATCH
Management is at its risk. If they start in Europe, the stock will improve. Therefore, be cautious.
biotechnology / pharmaceutical
DON'T BUY
Did an issue and it was a disaster. Hasn't even come close to where the issue was priced at. Behind schedule as compared to their competitors.
biotechnology / pharmaceutical
DON'T BUY
Still suffering from a plethora of disappointments from late 2001 and 2002. Will have a challenge moving up from where it is. Prefers others.
biotechnology / pharmaceutical
DON'T BUY
Volatile. Too few projects on the go. Risky.
biotechnology / pharmaceutical
DON'T BUY
Interesting technology. Future is unclear. Risky.
biotechnology / pharmaceutical
PAST TOP PICK
(Was a top pick on Dec 18 down 46%) Still likes. Got hit with the pull out of Aventis, but should be able to get new deals over the next 6 months. Don't buy until they do strike a deal.
biotechnology / pharmaceutical
DON'T BUY
Speculative and risky. In a competitive sector.
biotechnology / pharmaceutical
Showing 1 to 15 of 28 entries

Labopharm Inc(DDS-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Labopharm Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Labopharm Inc(DDS-T) Frequently Asked Questions

What is Labopharm Inc stock symbol?

Labopharm Inc is a OTC stock, trading under the symbol DDS-T on the (). It is usually referred to as or DDS-T

Is Labopharm Inc a buy or a sell?

In the last year, there was no coverage of Labopharm Inc published on Stockchase.

Is Labopharm Inc a good investment or a top pick?

Labopharm Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Labopharm Inc.

Why is Labopharm Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Labopharm Inc worth watching?

In the last year, there was no coverage of Labopharm Inc published on Stockchase.

What is Labopharm Inc stock price?

On , Labopharm Inc (DDS-T) stock closed at a price of $.